ESMO Press Releases

If you require further information regarding any of the press releases listed below, please do not hesitate to contact us (select 'Press & Media').


Date Title Topic
29 Sep 2015 ESMO Commentary: Specialised staff required for the nutrition and family teams in supportive care Palliative and supportive care
29 Sep 2015 ESMO Commentary: TOPGEAR results set to unify global treatment of gastric cancer Gastrointestinal cancers
28 Sep 2015 ESMO Commentary: Innovative approaches and drugs in early development phase show promising results in solid tumours Anticancer agents & Biologic therapy
28 Sep 2015 ESMO Commentary: A new promise for a rare skin cancer Cancer Immunology and Immunotherapy
28 Sep 2015 ESMO Commentary: Preserving fertility in breast cancer patients: new promises Breast cancer
28 Sep 2015 ESMO Commentary: Genomic landscape in lung cancer: steps forward in rapidly identifying genomic alterations Melanoma - Lung and other thoracic tumours
28 Sep 2015 ESMO Commentary: Preliminary Results from PERUSE Study Increase Treatment Options in HER-Positive Patients with Metastatic Breast Cancer Breast cancer
27 Sep 2015 ESMO Commentary: Atezolizumab Set to Change Refractory Lung Cancer Treatment Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
26 Sep 2015 ESMO Commentary: Migrants, Refugees and Neglected Patient Populations: nationality and social status still affect cancer care quality Bioethics, legal and economic issues
26 Sep 2015 ESMO Press Release: Six New Countries Join the List of ESMO Designated Centres of Integrated Oncology and Palliative Care Palliative and supportive care
23 Sep 2015 Press Release: ESMO Announces Christoph Zielinski as Editor-in-Chief 
of New Open Access Journal
27 Aug 2015 ESMO Press Release: ESMO Launches Women for Oncology Award
24 Aug 2015 ESMO Press Release: ESMO Honours Exceptional Oncologists
16 Jul 2015 ESMO Press Release: Five Days to Decide on a Professional Life: ESMO-ESO Course on Medical Oncology for Medical Students
04 Jul 2015 World GI 2015 Press Release: Second-line Cetuximab Active Beyond Progression in Quadruple Wild-type Patients with Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy